Cointime

InfiNovo

company

About

A global developer & provider of Glucose Continuous Monitoring system for diabetic patients

Highlights

Funding Rounds
1
Investors
2

Details

Last Funding Type
Series A
Founded date
Jan 1, 2016
Operating Status
Active

Infinovo was formed in 2016. For the past several years, Infinovo has been focusing on developing an accurate and affordable CGM (Continuous Glucose Monitoring) for patients which will be available for both Type 1 and Type 2 Diabeties. The company has developed a CGM which can compete in the global market for accuracy, durability, and design.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
—
InfiNovo has raised a total of — in funding over 2 rounds. Their latest funding was raised on Apr 1, 2019 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 1, 2019 Series A — 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
InfiNovo is funded by 2 investors. Rays Venture Capital and Prosperico Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Rays Venture Capital — Series A
Prosperico Ventures — Series A
Cointime
เนื้อหา
บริษัท